Truong T

No ORCID on file · 7 papers in corpus
2023
Body mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: a national study.
F&S reports ·doi:10.1016/j.xfre.2022.11.014

ObjectiveTo evaluate the association between body mass index (BMI) and good perinatal outcomes after in vitro fertilization (IVF) among women with polycystic ovary syndrome (PCOS).DesignRetrospective cohort study using 2012-2015 Society for…

2023
Markers of ovarian reserve as predictors of future fertility.
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.10.014

ObjectiveTo determine the association between ovarian reserve biomarkers and future fertility among late reproductive-age women.DesignCohort study of participants enrolled in Time to Conceive (TTC), a time-to-pregnancy cohort study of the o…

2022
Impact of increasing antimüllerian hormone level on in vitro fertilization fresh transfer and live birth rate.
F&S reports ·doi:10.1016/j.xfre.2022.06.005

ObjectiveThe objective of our study was to assess the association between AMH and live birth among women with elevated AMH undergoing first fresh IVF. Serum antimüllerian hormone (AMH) correlates with oocyte yield during in vitro fertilizat…

2021
Can high antimüllerian hormone mitigate some of the age-related decline in live birth rates? The association between antimüllerian hormone and live birth among women over 40 undergoing in vitro fertilization.
F&S reports ·doi:10.1016/j.xfre.2021.08.009

ObjectiveTo examine the association between serum antimüllerian hormone (AMH) and live birth among women aged ≥41 years undergoing in vitro fertilization (IVF).DesignRetrospective cohort study using the 2012-2014 Society for Assisted Reprod…

2020
Prevalence of a Good Perinatal Outcome With Cryopreserved Compared With Fresh Donor Oocytes.
Obstetrics and gynecology ·doi:10.1097/aog.0000000000003695

ObjectiveTo compare the odds of a good perinatal outcome between cryopreserved and fresh donor oocytes.MethodsWe used the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System to conduct a retrospective cohort study …

2020
Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia.
PloS one ·doi:10.1371/journal.pone.0228187

BackgroundGSTM1 and GSTT1 are involved in detoxification of xenobiotics, products of oxidative stress and in steroid hormones metabolism. We investigated whether GSTM1 and GSTT1 gene deletion was associated with DTC risk and explored intera…

2016
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.04.034

ObjectiveClinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3' UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with …